Immunotherapy (ISSN 1750-743X) is a monthly peer-reviewed academic journal published by Future Medicine Ltd in the United Kingdom, serving as a leading venue for research dedicated to the field of immunotherapy. The journal encompasses a broad spectrum of scientific inquiry, ranging from fundamental immunological mechanisms to clinical translation and applications, with particular emphasis on tumor immunity, autoimmune diseases, and vaccine development. As a non-open access publication indexed in the Science Citation Index (SCI), it maintains a strong reputation for high-quality scholarship, although authors and readers should consult the latest Journal Citation Reports (JCR) and the Chinese Academy of Sciences (CAS) journal ranking tables for current impact factor metrics and classification details, as these values may fluctuate annually. While the subscription-based access model may limit immediate open availability for some readers, the journal remains a respected and authoritative resource for researchers, clinicians, and academics seeking to engage with rigorous studies in immunotherapeutic strategies.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com